(Q38925669)

7 September 2017

title

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis (English)

1 reference

7 September 2017

Yanchun Li

1

1 reference

7 September 2017

Jocelyn C Reader

2

1 reference

7 September 2017

Xinrong Ma

3

1 reference

7 September 2017

Namita Kundu

4

1 reference

7 September 2017

Tyler Kochel

5

1 reference

7 September 2017

Amy M Fulton

6

1 reference

7 September 2017

language of work or name

English

0 references

publication date

24 December 2014

1 reference

Breast Cancer Research and Treatment

7 September 2017

published in

1 reference

7 September 2017

volume

149

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

403-415

1 reference

The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

The association of CXCR3 and renal cell carcinoma metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3229-7

Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25537642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CXCR3, a double-edged sword in tumor progression and angiogenesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25537642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-014-3229-7

1 reference

Dimensions Publication ID

7 September 2017

1024520692

0 references

1 reference